Join your clinician colleagues and expert faculty for PrimaryCareNOW: A Pri-Med Virtual Conference on Thursday–Friday, November 18–19. This free remote learning experience includes:
- A carefully curated CME/CE curriculum, moderated by Ty J. Gluckman, MD, FACC, FAHA, and Pamela Kushner, MD, FAAFP
- Interactive, live Q&A with distinguished faculty, including experts from top healthcare institutions across the country
- The opportunity to earn up to 12.00 AMA PRA Category 1 Credits™ and 12.00 ABIM Medical Knowledge MOC Points, or 12.00 AANP contact hours of continuing education, including 4.29 hour of pharmacology
- Access to on-demand CME/CE courses
Your free registration includes the full conference, but you're welcome to join the sessions that best fit your schedule. Agenda and details are subject to change.
To register for this virtual conference, you will be asked to sign in to your Pri-Med account. If you do not have an account, you can create your free account now, which takes less than two minutes.
Agenda
CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
8–9am ET CME/CE Accredited Session
Curbside Consults: Top Questions from PCPs About... HIV and Acne/Rosacea
Howard Libman, MD | Jacob Levitt, MD, FAAD
What do primary care providers need to know about HIV and Acne/Rosacea? Join expert faculty as they review important questions they get asked about these topics!
Howard Libman, MD
Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA
Jacob Levitt, MD, FAAD
Professor and Vice Chairman, Department of Dermatology, Mount Sinai Medical Center, New York, NY
9:10–10:10am ET CME/CE Accredited Session
Treatment Escalation for Patients With Major Depressive Disorder
Pamela Kushner, MD, FAAFP | Jeffrey Rado, MD, MPH, FAPA
Have you ever been stuck wondering what the best next steps are for your patients with major depressive disorder (MDD) who do not respond fully to initial pharmacotherapy? This session will provide evidence-based strategies for recognizing and treating patients with MDD who suffer from incompletely treated MDD—a circumstance that is more common that many realize, and which has serious health and psychosocial consequences. You will leave this session better equipped to identify these patient and formulate individualized plans to advance their care beyond initial monotherapy.
Pamela Kushner, MD, FAAFP
Clinical Professor, Director, Kushner Wellness, UC Irvine Medical Center, Orange, CA
Jeffrey Rado, MD, MPH, FAPA
Associate Professor, Northwestern University Feinberg School of Medicine, Chicago, IL
Supported by Otsuka America Pharmaceutical, Inc. and Lundbeck
10:20–11:05am ET Non-CME Industry Theater
Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
Sponsored by Novo Nordisk Inc.
10:20–11:05am ET Non-CME Industry Theater
- Review updated treatment paradigms for severe asthma.
- Evaluate the benefit-risk of oral corticosteroid use in severe uncontrolled asthma and the need for OCS stewardship.
- Discuss the role of biologics as a preferred treatment option for severe asthma management.
Sponsored by AstraZeneca Pharmaceuticals, LP
11:15am–12:15pm ET CME/CE Accredited Session
A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies
Silvio E. Inzucchi, MD | Anne Peters, MD
More than half of patients with type 2 diabetes are obese. Modest and sustained weight loss has been shown to improve glycemic control and reduce the need for glucose-lowering medications in patients with type 2 diabetes who are obese. Despite the proven benefits of weight loss, most patients remain on therapeutic regimens that focus solely on lowering A1c. This program will provide evidence-based strategies for managing both glycemic and metabolic outcomes and explore the role of the incretin hormones GLP-1 and GIP in the treatment of type 2 diabetes and its metabolic comorbidities.
Silvio E. Inzucchi, MD
Professor of Medicine, Clinical Chief, Endocrinology, Medical Director, Yale Diabetes Center, Yale School of Medicine, Yale-New Haven Hospital, New Haven, CT
Anne Peters, MD
Professor of Clinical Medicine, Keck School of Medicine of USC, Los Angeles, CA
Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
12:25–1:25pm ET CME/CE Accredited Session
Hope For Patients with Hepatocellular Carcinoma: A Call to Action for Primary Care Providers
Amit Singal, MD, MS | Ghassan Abou-Alfa, MD, MBA
Hepatocellular carcinoma (HCC) screening can improve survival for patients, but it is underused in clinical practice. Join two faculty experts as they discuss the urgency for early identification of HCC in primary care. Learn about the changing epidemiology of HCC and how primary care providers (PCPs) can support patients during their journey. This program also features patient videos and interactive Q&A sessions.
Amit Singal, MD, MS
Professor of Medicine, Willis C. Maddrey Chair in Liver Disease, Chair of Hepatology, Medical Directory of Liver Tumor Program, UT Southwestern Medical Center, Dallas, TX
Ghassan Abou-Alfa, MD, MBA
Attending Physician, Memorial Sloan-Kettering Cancer Center, Professor of Medicine, Weill Medical College, Cornell University, New York, NY
Supported by Supported by an educational grant from Genentech, a member of the Roche Group.
1:35–2:20pm ET Non-CME Industry Theater
Matt T Rosenberg, MD
Matt T Rosenberg, MD
Consultant of Urovant Sciences
Sponsored by Urovant Sciences
1:35–2:20pm ET Non-CME Industry Theater
Alan M. Rapoport, MD
This product theater will focus on the commitment AbbVie has to migraine patients by highlighting two oral CGRP receptor antagonists that directly block CGRP.
Alan M. Rapoport, MD
Clinical Professor of Neurology, at The David Geffen School of Medicine at UCLA
Sponsored by AbbVie
2:30–3:30pm ET CME/CE Accredited Session
Curbside Consults: Top Questions from PCPs in Asthma and COPD
Sunjay R. Devarajan, MD | Nicola Hanania, MD, MS, FCCP, FACP, FRCP (C)
What do primary care providers need to know about asthma and COPD? Join expert faculty as they review important questions they get asked about these topics!
Sunjay R. Devarajan, MD
Professor Division of Pulmonary & Critical Care, Baylor College of Medicine, Houston, TX
Nicola Hanania, MD, MS, FCCP, FACP, FRCP (C)
Director, Airways Clinical Research Center, Baylor College of Medicine, Houston, TX, Interim Chief, Section of Pulmonary, Critical Care and Sleep Medicine, Ben Taub Hospital, Houston, TX
3:40–4:40pm ET CME/CE Accredited Session
4:50–5:35pm ET Non-CME Industry Theater
Clinical Considerations in Coronary Artery Disease
Ted Okerson, MD, FACP, FACE
- Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
- Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population.
- Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial.
Ted Okerson, MD, FACP, FACE
Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.
Sponsored by AstraZeneca Pharmaceuticals, LP
8–9am ET CME/CE Accredited Session
Challenging Cases in Urgent Care
R. Michelle Schmidt, MD, MPH
Throughout this 60-minute session, learners will review cases that are commonly seen in an urgent care setting, understand problems that are frequently encountered in an urgent care, and know how to best approach these issues to benefit both the health care provider and the patient. Participants will learn when patients may avoid a trip to the urgent care center and when providers should refer to a specialist. Additionally, learners will review cases that highlight certain problems that primary care providers may encounter in their practices.
R. Michelle Schmidt, MD, MPH
Assistant Professor, Section of General Medicine, Baylor College of Medicine, Houston, TX
9:10–10:10am ET CME/CE Accredited Session
Digital Technology: The Present and Future of Diabetes Care
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES | Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
You know that insulin therapy is an important tool in improving quality of life and health outcomes for your patients with diabetes, but are you familiar with the expanding array of diabetes technology that can play an important role in improving insulin delivery and management? Do you know how to optimally use these tools? After this activity, you’ll be able to interpret continuous glucose monitoring data to improve time-in-range, minimize hypoglycemia, and reduce postprandial glycemic excursions. Don’t miss this opportunity to learn how to incorporate diabetes technology into clinical practice to optimize insulin management, bolster patients’ confidence in self-management of their diabetes, and, ultimately, improve health outcomes.
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES
CGM & Remote Monitoring Program Coordinator, Cleveland Clinic Diabetes Center, Cleveland, OH
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
Board Certified Adult Health and Advanced Diabetes Management, President and Owner, Diabetes Consulting Services, Co-Executive Director, Capital Health & Metabolic Center, Capital Diabetes & Endocrine Associates, Silver Spring, MD
Supported by Novo Nordisk, Inc
10:20–11:05am ET Non-CME Industry Theater
Aaron P. Milstone, MD, FCCP
Join us to learn about a maintenance therapy for the treatment of COPD.
Aaron P. Milstone, MD, FCCP
Medical Director, Williamson Pulmonary and Sleep Medicine, Williamson Medical Group
Sponsored by Viatris and Theravance Biopharma
10:20–11:05am ET Non-CME Industry Theater
Discuss the diagnosis of Exocrine Pancreatic Insufficiency (EPI) and the treatment with CREON.
Sponsored by AbbVie
11:15am–12:15pm ET CME/CE Accredited Session
Incretin-Based Multiagonist Therapy: Emerging Treatment for Obesity and Diabetes
Jennifer B. Green, MD | Robert F. Kushner, MD, FACP
Given that 9 out of 10 people with diabetes also suffer from overweight or obesity, it is important for PCPs to take a holistic approach to treatment rather than solely a glucocentric approach. This activity helps you understand the benefits of weight loss as a key therapeutic strategy in the treatment of type 2 diabetes mellitus (T2DM) and the importance of early treatment intensification to improve long-term outcomes. You’ll also walk away from this session with a firm grasp of the role incretins play in the pathophysiology of T2DM, obesity, and other metabolic conditions and the latest clinical trial evidence behind incretin-based agents.
Jennifer B. Green, MD
Associate Professor of Medicine, Department of Medicine, Division of Endocrinology, Faculty Member, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
Robert F. Kushner, MD, FACP
Professor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
12:25–1:25pm ET CME/CE Accredited Session
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Philip Schoenfeld, MD, MSEd, MSc
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..
1:35–2:20pm ET Non-CME Industry Theater
Patients with peripheral artery disease (PAD), including patients after lower-extremity revascularization due to symptomatic PAD are risk for major thrombotic vascular events. This lecture will discuss an approach to reducing the risk of these events.
Sponsored by Janssen Pharmaceuticals, Inc.
1:35–2:20pm ET Non-CME Industry Theater
Neil Skolnik, MD
This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.
Neil Skolnik, MD
Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Sponsored by GlaxoSmithKline
2:30–3:30pm ET CME/CE Accredited Session
Curbside Consults: Top Questions from PCPs in... SSRI and Dementia
Jeffrey Rado, MD, MPH, FAPA
What do primary care providers need to know about SSRI and dementia? Join expert faculty as they review important questions they get asked about these topics!
Jeffrey Rado, MD, MPH, FAPA
Associate Professor, Northwestern University Feinberg School of Medicine, Chicago, IL
3:40–4:40pm ET CME/CE Accredited Session
Nutrition Tips for Primary Care: Strategies from a Dietician Beyond the Basics
Bethany Doerfler, MS, RDN
Nutrition research and recommendations are rapidly changing. Fill your toolbox with behavioral and food driven action plans to answer your patients' toughest Nutrition and lifestyle issues.
Updated recommendations for nutrition advice for IBS, intermittent fasting, popular diets, food intolerances and more will be answered.
Bethany Doerfler, MS, RDN
Clinical Research Dietitian, Division of Gastroenterology & Hepatology, Northwestern University, Feinberg School of Medicine, Adjunct Faculty, Marciella School of Nursing, Loyola University, Chicago, IL
4:50–5:35pm ET Non-CME Industry Theater
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Brett Smith, DO
- Understand the causes and prevalence of chronic low back pain.
- Differentiate inflammatory back pain (IBP) from mechanical back pain.
- Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
- Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.
Brett Smith, DO
Sponsored by AbbVie